Where is PhRMA in mifepristone debate?; cancer patients consider 'time toxicity'

PhRMA hasn't put out a press release about a Texas judge suspending the pill's approval, even though the ruling could destabilize the FDA.

April 10, 2023 Check out STAT+

Sponsored By

Gabriela Bhaskar/The New York Times Where is PhRMA in the mifepristone debate? A judge's decision to suspend FDA approval of an abortion pill could impact pharma, but its lobbying association is staying on the sidelines. By Rachel Cohrs STAT+ | 5 to watch: Tech startups trying to solve health care's staffing crisis These tech startups are developing tools to help hospitals deal with the urgent need to hire and schedule nurses and other health workers. By Ambar Castillo Next abortion battles may be among states with clashing laws There's no legal precedent giving good guidance about whether states can influence their residents getting an abortion outside their borders. By Geoff Mulvihill and John Hanna — Associated Press Caroline Yang for STAT Here's a new data point for cancer patients to consider: 'time toxicity' Some researchers say treatment studies should calculate how much of a patient's additional survival time would be spent simply getting care. By Charlotte Huff STAT+ | UnitedHealth's physician buying spree continues with takeover of Crystal Run With no fanfare, UnitedHealth Group has acquired Crystal Run Healthcare, a prominent physician group in New York. By Bob Herman Opinion: Why genetic testing should always be offered to children with neurodevelopmental differences The medical system is failing the rare disease community by vastly underdiagnosing genetic disorders in children with developmental delays. By Deborah Ondrasik

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser